Download PDF
Thromb Haemost 1998; 80(01): 207-208
DOI: 10.1055/s-0037-1615170
Letters to the Editor
Schattauer GmbH

Complex Control of Vascular Smooth Muscle Cell Growth by Thromboxane A2

Authors

  • Artur-Aron Weber

    1   Institut für Pharmakologie der Heinrich-Heine-Universität Düsseldorf, Germany

  • Karsten Schrör

    1   Institut für Pharmakologie der Heinrich-Heine-Universität Düsseldorf, Germany
Further Information

Publication History

Received 12 March 1998

Accepted 31 March 1998

Publication Date:
08 December 2017 (online)

   Permissions and Reprints
Preview

 

 

  • References

  • 1 Grosser T, Zucker T-P, Weber A-A, Schulte K, Sachinidis A, Vetter H, Schrör K. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.. Eur J Pharmacol 1998; 319: 327-32.
    PubMedSearch in Google Scholar
  • 2 Zucker T-P, Bönisch D, Muck S, Weber A-A, Bretschneider E, Glusa E, Schrör K. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA.. Circulation 1998; 97: 589-95.
    CrossrefPubMedSearch in Google Scholar
  • 3 Jones DA, Benjamin CW, Linseman DA. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.. Mol Pharmacol 1995; 48: 890-6.
    PubMedSearch in Google Scholar
  • 4 Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.. Circulation 1998; 96: 2280-6.
    PubMedSearch in Google Scholar
  • 5 Muck S, Weber A-A, Meyer-Kirchrath J, Schrör K. The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization.. Naunyn-Schmiedeberg’s Arch Pharmacol 1998; 357: 10-6.
    PubMedSearch in Google Scholar